查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1631120

重症加护诊断市场规模、份额、趋势分析报告（按类型、最终用途、地区、细分市场预测），2025 年至 2030 年

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

重症加护诊断市场的成长和趋势

根据 Grand View Research, Inc. 的一份新报告，全球重症加护诊断市场预计到 2030 年将达到 21 亿美元。

预计 2025 年至 2030 年间，市场复合年增长率为 6.11%。支持该行业成长的关键因素是医生和患者对这些测试的快速认识和接受、老年人口和慢性健康状况的增加、偏远地区采用远距远端医疗服务以及技术的进步。分子诊断成本的上升和技术纯熟劳工的短缺预计将阻碍该行业的发展。

重症加护诊断市场按类型细分为常规和特种化学、流式细胞技术、血液学、免疫蛋白、微生物学和感染疾病、血液凝固检验等。预计预测期内微生物学和传染病检查检测诊断领域将以超过 7.24% 的最高复合年增长率成长。例如，卫生系统投入大量资源收集和处理血液培养以进行病原体鑑定。

重症加护诊断测试，例如核酸增幅检查，使临床医生能够更快、更准确地检测和识别细菌，为希望尽快开展适当的抗菌治疗并停止使用可避免药物的临床医生提供指南。根据最终用途，重症加护诊断市场分为手术室、急诊室和ICU。预计预测期内急诊室部分将出现最高的成长率。

重症加护诊断市场报告重点

  • 预计预测期内亚太地区将以最快的速度成长，复合年增长率为 8.0%。人口老化、慢性病盛行率上升、亚太地区专科医院数量的增加以及农村地区医疗服务和基础设施的改善是推动市场成长的一些因素。
  • 就重症加护诊断市场的类型份额而言，免疫蛋白诊断测试部分估计占有最大的份额。对快速且准确的预防性医疗保健服务的需求不断增长是推动这一市场成长的主要因素之一。
  • 根据最终用途，约有 20% 的急诊护理患者被送入 ICU，而约有 58% 的急诊患者被送入急诊室。预计在预测期内，急诊室部分将以最高的复合年增长率呈指数增长。近期患者对急诊室服务的需求增加，是因为急诊室能够为重症患者提供初步的急性护理诊断和治疗。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
  • 市场限制因素分析
  • 商业环境分析
    • 依因素（政治/法律、经济/技术）进行 SWOT 分析
    • 波特五力分析

第四章 类型业务分析

  • 重症加护诊断市场：类型变化分析
  • 常规和特种化学
    • 常规化学品和特种化学品市场，2018 至 2030 年
  • 流式细胞技术
    • 流式细胞技术市场，2018 - 2030
  • 血液学
    • 血液学市场 2018-2030
  • 免疫蛋白
    • 免疫蛋白市场，2018-2030
  • 微生物与感染疾病
    • 微生物学和感染疾病市场，2018-2030 年
  • 血液凝固检验
    • 血液凝固检验市场，2018 - 2030 年
  • 其他的
    • 其他市场，2018-2030

第五章 最终用途业务分析

  • 重症加护诊断市场：最终用途变异分析
  • 手术室
    • 2018 至 2030 年手术室市场
  • 加护病房
    • 加护病房市场，2018 - 2030 年
  • 急诊室
    • 急诊室市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第六章 区域经营分析

  • 2024 年及 2030 年重症加护诊断市场占有率（按地区）
  • 北美洲
    • 2018 至 2030 年北美加护治疗诊断市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018 至 2030 年欧洲主要诊断市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018 年至 2030 年亚太地区重症监护诊断市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018 至 2030 年拉丁美洲加护治疗诊断市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018 年至 2030 年中东和非洲主要诊断市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 公司分类
  • 战略地图
  • 2024 年公司市场占有率分析
  • 公司简介/上市公司
    • Abbott
    • Danaher
    • Siemens Healthineers
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • bioMerieux SA
    • Chembio Diagnostics, Inc.
    • EKF Diagnostics
    • Bayer AG
Product Code: GVR-1-68038-010-1

Critical Care Diagnostics Market Growth & Trends:

The global critical care diagnostics market size is expected to reach USD 2.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.11% from 2025 to 2030. The key factors supporting the industry's growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 7.24% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU's. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Critical Care Diagnostics Market Report Highlights:

  • The Asia Pacific region is expected to grow at the fastest CAGR of 8.0% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.
  • The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.
  • On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU's, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Critical Care Diagnostics Market: Type Movement Analysis
  • 4.2. Routine & Special Chemistry
    • 4.2.1. Routine & Special Chemistry Market, 2018 - 2030 (USD Million)
  • 4.3. Flow Cytometry
    • 4.3.1. Flow Cytometry Market, 2018 - 2030 (USD Million)
  • 4.4. Hematology
    • 4.4.1. Hematology Market, 2018 - 2030 (USD Million)
  • 4.5. Immunoproteins
    • 4.5.1. Immunoproteins Market, 2018 - 2030 (USD Million)
  • 4.6. Microbial & Infectious Disease
    • 4.6.1. Microbial & Infectious Disease Market, 2018 - 2030 (USD Million)
  • 4.7. Coagulation Testing
    • 4.7.1. Coagulation Testing Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-use Business Analysis

  • 5.1. Critical Care Diagnostics Market: End-use Movement Analysis
  • 5.2. Operation Room
    • 5.2.1. Operation Room Market, 2018 - 2030 (USD Million)
  • 5.3. Intensive Care Unit
    • 5.3.1. Intensive Care Unit Market, 2018 - 2030 (USD Million)
  • 5.4. Emergency Rooms
    • 5.4.1. Emergency Rooms Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Critical Care Diagnostics Market Share By Region, 2024 & 2030
  • 6.2. North America
    • 6.2.1. North America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. Regulatory Framework
      • 6.2.2.5. Reimbursement Scenario
      • 6.2.2.6. U.S. Critical Care Diagnostics Market, 2018 - 2030 (USD MILLION)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Regulatory Framework
      • 6.2.3.5. Reimbursement Scenario
      • 6.2.3.6. Canada Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Target Disease Prevalence
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Regulatory Framework
      • 6.2.4.5. Reimbursement Scenario
      • 6.2.4.6. Mexico Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Critical diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Regulatory Framework
      • 6.3.2.5. Reimbursement Scenario
      • 6.3.2.6. Germany Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Regulatory Framework
      • 6.3.3.5. Reimbursement Scenario
      • 6.3.3.6. UK Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Regulatory Framework
      • 6.3.4.5. Reimbursement Scenario
      • 6.3.4.6. France Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Regulatory Framework
      • 6.3.5.5. Reimbursement Scenario
      • 6.3.5.6. Italy Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Regulatory Framework
      • 6.3.6.5. Reimbursement Scenario
      • 6.3.6.6. Spain Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Regulatory Framework
      • 6.3.7.5. Reimbursement Scenario
      • 6.3.7.6. Denmark Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Regulatory Framework
      • 6.3.8.5. Reimbursement Scenario
      • 6.3.8.6. Sweden Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Regulatory Framework
      • 6.3.9.5. Reimbursement Scenario
      • 6.3.9.6. Norway Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Regulatory Framework
      • 6.4.2.5. Reimbursement Scenario
      • 6.4.2.6. Japan Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Regulatory Framework
      • 6.4.3.5. Reimbursement Scenario
      • 6.4.3.6. China Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
      • 6.4.4.5. Reimbursement Scenario
      • 6.4.4.6. India Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Regulatory Framework
      • 6.4.5.5. Reimbursement Scenario
      • 6.4.5.6. South Korea Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Regulatory Framework
      • 6.4.6.5. Reimbursement Scenario
      • 6.4.6.6. Australia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Regulatory Framework
      • 6.4.7.5. Reimbursement Scenario
      • 6.4.7.6. Thailand Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Regulatory Framework
      • 6.5.2.5. Reimbursement Scenario
      • 6.5.2.6. Brazil Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Regulatory Framework
      • 6.5.3.5. Reimbursement Scenario
      • 6.5.3.6. Argentina Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Critical diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Regulatory Framework
      • 6.6.2.5. Reimbursement Scenario
      • 6.6.2.6. South Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Regulatory Framework
      • 6.6.3.5. Reimbursement Scenario
      • 6.6.3.6. Saudi Arabia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Regulatory Framework
      • 6.6.4.5. Reimbursement Scenario
      • 6.6.4.6. UAE Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Regulatory Framework
      • 6.6.5.5. Reimbursement Scenario
      • 6.6.5.6. Kuwait Critical Care Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Abbott
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Collection Site Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Collection Site Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Siemens Healthineers
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Collection Site Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. F. Hoffmann-La Roche Ltd.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Collection Site Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Quidel Corporation
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Collection Site Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. bioMerieux S.A
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Collection Site Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Chembio Diagnostics, Inc.
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Collection Site Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. EKF Diagnostics
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Collection Site Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Bayer AG
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Collection Site Benchmarking
      • 7.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 Global Critical Care Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 11 Mexico Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 Mexico Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 18 Germany Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Germany Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 UK Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 UK Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 22 France Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 France Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 24 Italy Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Italy Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 Spain Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Spain Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 28 Denmark Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 Denmark Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 Sweden Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Sweden Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Norway Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Norway Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 China Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 China Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Japan Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Japan Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 India Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 India Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 43 South Korea Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 44 South Korea Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Australia Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Australia Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 47 Thailand Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 Thailand Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Latin America Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 50 Latin America Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Latin America Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 Brazil Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Brazil Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Argentina Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Argentina Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Critical Care Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 59 South Africa Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 UAE Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 UAE Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Critical Care Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Critical Care Diagnostics Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Critical Care Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Critical Care Diagnostics Market: Type Movement Analysis
  • Fig. 16 Global Critical Care Diagnostics Market, for Routine & Special Chemistry, 2018 - 2030 (USD Million)
  • Fig. 17 Global Critical Care Diagnostics Market, for Flow Cytometry, 2018 - 2030 (USD Million)
  • Fig. 18 Global Critical Care Diagnostics Market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 19 Global Critical Care Diagnostics Market, for Immunoproteins, 2018 - 2030 (USD Million)
  • Fig. 20 Global Critical Care Diagnostics Market, for Microbial & Infectious Disease, 2018 - 2030 (USD Million)
  • Fig. 21 Global Critical Care Diagnostics Market, for Coagulation Testing, 2018 - 2030 (USD Million)
  • Fig. 22 Global Critical Care Diagnostics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Global Critical Care Diagnostics Market: End-use Movement Analysis
  • Fig. 24 Global Critical Care Diagnostics Market, for Operation Room, 2018 - 2030 (USD Million)
  • Fig. 25 Global Critical Care Diagnostics Market, for Intensive Care Unit, 2018 - 2030 (USD Million)
  • Fig. 26 Global Critical Care Diagnostics Market, for Emergency Rooms, 2018 - 2030 (USD Million)
  • Fig. 27 Global Critical Care Diagnostics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 28 Regional Marketplace: Key Takeaways
  • Fig. 29 Regional Outlook, 2024 & 2030
  • Fig. 30 Global Critical Care Diagnostics Market, Region Movement Analysis
  • Fig. 31 North America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 38 France Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 46 China Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 47 India Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Critical Care Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Critical Care Diagnostics Market, 2018 - 2030 (USD Million)